Cytek Biosciences, Inc. (NASDAQ:CTKB) Q4 2025 Earnings Call Transcript February 26, 2026
Cytek Biosciences, Inc. misses on earnings expectations. Reported EPS is $-0.3439 EPS, expectations were $0.02.
Operator: Thank you for standing by. My name is Tina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Cytek Biosciences Fourth Quarter 2025 Earnings Call. [Operator Instructions] It is now my pleasure to turn the call over to Paul Goodson,...
